Skip to main content
Clinical Trials/ChiCTR2200057510
ChiCTR2200057510Not yet recruitingNot Applicable

阿芬太尼用于体外循环心脏手术患者围术期疼痛治疗研究

学术团体1 site in 1 country436 target enrollmentStarted: February 14, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
436
Locations
1
Primary Endpoint
疼痛视觉模拟评分

Study Overview

Brief Summary

评价阿芬太尼对体外循环麻醉下心脏手术患者术中疼痛治疗的有效性、安全性、以及对术后疼痛、苏醒质量的影响。

Study Design

Study Type
干预性研究
Primary Purpose
横断面

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • •1.择期体外循环麻醉下心脏瓣膜手术(预计手术时间大于 2h,排除腔镜小切口手术);
  • •2.年龄 18-65 岁;
  • •3.心功能 II-IV 级;

Exclusion Criteria

  • •1.不能完成量表评估的患者;
  • •2.合并精神疾病史、慢性疼痛史、酒精或毒品滥用史;
  • •3.肝肾功能明显异常(转氨酶升高 2 倍及以上);
  • •4.对阿片类药物过敏史;
  • •5.BMI≥30kg/m^2;
  • •6.妊娠期、哺乳期妇女。

Arms & Interventions

舒芬太尼组

围术期均用舒芬太尼镇痛

Intervention: 围术期均用舒芬太尼镇痛

阿芬太尼组

围术期均用阿芬太尼镇痛

Intervention: 围术期均用阿芬太尼镇痛

Outcomes

Primary Outcomes

疼痛视觉模拟评分

Time Frame: 术后 2h、6h、12h、24h、36h、48h、5d

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
学术团体

Study Sites (1)

Loading locations...

Similar Trials